PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)
US10682336B2 · kind B2 · utility
0Cited by
36References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2016 |
| Grant date | Jun 16, 2020 |
| Priority date | — |
| Expiry date | Oct 20, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating immune reconstitution inflammatory syndrome (IRIS) in immunodeficient patients, including HIV patients, using PDE4 modulators are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.